1. Home
  2. NAMS vs FBK Comparison

NAMS vs FBK Comparison

Compare NAMS & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • FBK
  • Stock Information
  • Founded
  • NAMS 2019
  • FBK 1906
  • Country
  • NAMS Netherlands
  • FBK United States
  • Employees
  • NAMS N/A
  • FBK N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • FBK Major Banks
  • Sector
  • NAMS Health Care
  • FBK Finance
  • Exchange
  • NAMS Nasdaq
  • FBK Nasdaq
  • Market Cap
  • NAMS 2.7B
  • FBK 2.6B
  • IPO Year
  • NAMS N/A
  • FBK 2016
  • Fundamental
  • Price
  • NAMS $23.54
  • FBK $53.43
  • Analyst Decision
  • NAMS Strong Buy
  • FBK Hold
  • Analyst Count
  • NAMS 7
  • FBK 6
  • Target Price
  • NAMS $38.17
  • FBK $48.67
  • AVG Volume (30 Days)
  • NAMS 538.3K
  • FBK 161.2K
  • Earning Date
  • NAMS 02-06-2025
  • FBK 01-21-2025
  • Dividend Yield
  • NAMS N/A
  • FBK 1.28%
  • EPS Growth
  • NAMS N/A
  • FBK N/A
  • EPS
  • NAMS N/A
  • FBK 2.48
  • Revenue
  • NAMS $33,594,000.00
  • FBK $443,569,000.00
  • Revenue This Year
  • NAMS $131.53
  • FBK N/A
  • Revenue Next Year
  • NAMS N/A
  • FBK $10.45
  • P/E Ratio
  • NAMS N/A
  • FBK $21.46
  • Revenue Growth
  • NAMS 78.77
  • FBK N/A
  • 52 Week Low
  • NAMS $15.19
  • FBK $33.35
  • 52 Week High
  • NAMS $27.29
  • FBK $58.88
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.28
  • FBK 56.14
  • Support Level
  • NAMS $23.17
  • FBK $51.54
  • Resistance Level
  • NAMS $26.71
  • FBK $54.04
  • Average True Range (ATR)
  • NAMS 0.94
  • FBK 1.33
  • MACD
  • NAMS -0.40
  • FBK 0.41
  • Stochastic Oscillator
  • NAMS 23.65
  • FBK 89.91

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

Share on Social Networks: